Type(s) of Cancer
Lung
Lung
Study Phase
Phase 3
Study Completion Date
January 2019
January 2019
NCT01107626Uploaded 03-15-2023
Access via NCI by Request
PDS UID: nci-data-508
Randomized Phase III Study of Maintenance Therapy With Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Files: NCT01107626-D1



Data DictionaryNCT01107626-D1-Data-Dictionary_1.pdf

DATANCT01107626-D1-Dataset_6.csv

OTHERREADME.pdf
Files: NCT01107626-D2



Data DictionaryNCT01107626-D2-Data-Dictionary_1.pdf

DATANCT01107626-D2-Dataset_4.csv

OTHERREADME.pdf